The Carbon Impact of Biotech & Pharma Virtual Event
To unveil our groundbreaking study determining the carbon impact of the global biotechnology and pharmaceutical industry, we hosted an event at the COP26 2021 United National Climate Conference, on Nov 5, 2021. This event was held at the World Health Organization COP26 Health Pavilion, and featured a remarkable panel of experts.
This study, the first to quantify the scope 1, 2 and 3 emissions of the biotech and pharmaceutical industry-
The event panelists included-
- Outlines the magnitude of the carbon impact
- Places it in the context of other carbon intensive industries
- Identifies key hotspots and leverage point for the industry to transform to reduce impact in line with the Paris Climate Agreement
The event panelists included-
- James Connelly, CEO, My Green Lab
- Dr. Fiona Adshead, Chair, Sustainable Healthcare Coalition
- Benjamin Norbury, Global Climate Lead, AstraZeneca
- Gail Sucharitakul, UNFCCC COP26 Climate Champions: Health and Tourism Sector Lead
- Girish Narula, CEO, Urgentem